Tanvex BioPharma Inc
TWSE:6541

Watchlist Manager
Tanvex BioPharma Inc Logo
Tanvex BioPharma Inc
TWSE:6541
Watchlist
Price: 57.9 TWD -3.66% Market Closed
Market Cap: 15.3B TWD

Dividends

Tanvex BioPharma Inc
does not pay dividends

Shareholder Yield

Current shareholder yield for Tanvex BioPharma Inc is hidden .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
HIDDEN
Show
Dividend Yield
No dividends
Buyback Yield
HIDDEN
Debt Paydown Yield
HIDDEN

Peers Comparison
Shareholder Yield

Company Total Yield Dividend Yield Buyback Yield Debt Paydown Yield

Buybacks

Buyback Yield measures how much a company reduces its outstanding shares through repurchases, expressed as a percentage.

This metric directly reflects the company’s efforts to return value to shareholders. By reducing the number of shares, buybacks can increase earnings per share and potentially boost the stock's price.

Unlock Buyback Yield

Peers Comparison
Buybacks

Company Buyback Yield Average Yield (3Y) Average Yield (5Y) Average Yield (10Y)

Debt Paydown

Debt Paydown Yield measures the amount of debt a company repays within a specific period, shown as a percentage of its market capitalization.

This metric indicates how the company is using its capital to decrease financial liabilities, which can strengthen its financial health and potentially enhance shareholder value.

Unlock Debt Paydown Yield

Peers Comparison
Debt Paydown

Company Debt Paydown Yield Average Yield (3Y) Average Yield (5Y) Average Yield (10Y)

Price Appreciation

Price
Tanvex BioPharma Inc

1M 1M
+12%
6M 6M
+11%
1Y 1Y
-6%
3Y 3Y
+58%
5Y 5Y
+57%
10Y 10Y
-75%
Annual Price Range
57.9
52w Low
48.1
52w High
81.8
Price Metrics
Average Annual Return 25.24%
Standard Deviation of Annual Returns 54.47%
Max Drawdown -69%
Shares Statistics
Market Capitalization 15.3B TWD
Shares Outstanding 264 820 000
Percentage of Shares Shorted
N/A

Return Decomposition
Main factors of price return

What is price return decomposition?

Stock Splits

Tanvex BioPharma Inc's latest stock split occurred on Mar 27, 2023

The company executed a 703-for-689 stock split, meaning that for every 689 shares held, investors received 703 new shares.

Before the split, Tanvex BioPharma Inc traded at 92.2261 per share. Afterward, the share price was about 91.5.

The adjusted shares began trading on Mar 27, 2023. This was Tanvex BioPharma Inc's 7th stock split, following the previous one in Mar 2, 2023.

Pre-Split Price
92.2261 92.2261
Post-Split Price
91.5
Before
After